APOPHARMA
Live / Registered — Registered — Section 8 accepted (as of 10 Jun 2023)
What this means for you
Registered since 13 Dec 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86958335
- Registration number
- 5099243
- Mark type
- Stylized text
- Filed
- 30 Mar 2016
- Published for opposition
- 27 Sept 2016
- Registered
- 13 Dec 2016
- Attorney of record
- Jessica G. Kraver
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, prescription drugs for the treatment of multiple myeloma by slowing the growth of cancer cells, prescription drugs for the treatment of multiple myeloma by stopping the growth of cancer cells, prescription drugs for palliative treatment of patients with multiple myeloma, and prescription drugs for use as an iron chelator for the treatment of patients with transfusion iron overload due to thalassemia syndromes
Owner
- APOTEX INC., TORONTO, CA
- Apotex Technologies Inc., Toronto, Ontario, CA
- Apotex Technologies Inc., Toronto, Ontario, CA
- Apotex Technologies Inc., Toronto, Ontario, CA
Prosecution history
- 13 Dec 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Jul 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 19 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Jul 2023 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 19 Jul 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 19 Jul 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 19 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Jun 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 10 Jun 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 10 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 13 Dec 2022 — TEAS SECTION 8 RECEIVED
- 13 Dec 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Jun 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 13 Dec 2016 — REGISTERED-PRINCIPAL REGISTER